chr21:33025935:> Detail (hg38)

Information

Genome

Assembly Position
hg19 chr21:34,398,243-34,401,504 
hg38 chr21:33,025,935-33,029,196

HGVS

Type Transcript Protein
Summary

MGeND

Clinical significance
Variant entry
GWAS entry
Disease area statistics Show details

Frequency

[No Data.]

Prediction

[No Data.]

ClinVar

Clinical Significance
Review star [No Data.]
Show details
Links
Disease area statistics
[No Data.]
MGeND
[No Data.]
ClinVar
[No Data.]
CIViC
[No Data.]
DisGeNET
Score Disease name Description Source Pubmed Links
0.121 Down syndrome NA BeFree,CTD_human Detail
<0.001 Ependymoma NA BeFree Detail
<0.001 ganglioneuroma NA BeFree Detail
0.009 glioblastoma Identification of OLIG2 as the most specific glioblastoma stem cell marker start... BeFree,LHGDN 25384509 Detail
0.009 glioblastoma OSM enhanced transcript and protein level of fibronectin and YKL-40 and reduced ... BeFree,LHGDN 25748242 Detail
0.009 glioblastoma Induction of the miR-302/367 cluster in extensively mutated U87MG glioblastoma c... BeFree,LHGDN 25991553 Detail
0.007 Glioma Olig2 labeling index is correlated with histological and molecular classificatio... BeFree,LHGDN 25085214 Detail
0.007 Glioma OLIG2, a proliferation regulator and glioma progenitor cell marker upregulated i... BeFree,LHGDN 25365423 Detail
0.003 leukemia NA BeFree,LHGDN Detail
<0.001 Leukemia, Myelocytic, Acute NA BeFree Detail
<0.001 Lung Neoplasms Re-expression of MAL and OLIG2 to physiological levels dramatically reduced the ... BeFree 24469050 Detail
<0.001 medulloblastoma NA BeFree Detail
0.003 melanoma NA LHGDN Detail
<0.001 obsessive-compulsive disorder NA BeFree Detail
0.008 oligodendroglioma The means of Olig2 LI in glioma cells were 43.7 % in diffuse astrocytomas, 59.3 ... BeFree,LHGDN 25085214 Detail
<0.001 osteochondritis dissecans NA BeFree Detail
<0.001 polyps NA BeFree Detail
0.012 schizophrenia NA BeFree,GAD,LHGDN Detail
<0.001 Spinal Cord Neoplasms Immunohistochemical and ultrastructural observations revealed that all the tumor... BeFree 24612193 Detail
<0.001 Gilles de la Tourette syndrome NA BeFree Detail
<0.001 Central Nervous System Neoplasms NA BeFree Detail
0.120 Muscle Weakness NA CTD_human Detail
<0.001 osteochondritis dissecans Five SNPs achieved 0.004 (the nominal p-value expected by chance), 3 with empiri... BeFree 23337130 Detail
<0.001 anorexia nervosa Five SNPs achieved 0.004 (the nominal p-value expected by chance), 3 with empiri... BeFree 23337130 Detail
<0.001 obsessive-compulsive disorder Five SNPs achieved 0.004 (the nominal p-value expected by chance), 3 with empiri... BeFree 23337130 Detail
<0.001 Neuroectodermal Tumors NA BeFree Detail
<0.001 Neuroectodermal Tumor, Primitive NA BeFree Detail
<0.001 Neoplasms, Neuroepithelial NA BeFree Detail
<0.001 central neurocytoma NA BeFree Detail
<0.001 extraosseous Ewings sarcoma-primitive neuroepithelial tumor NA BeFree Detail
<0.001 diffuse astrocytoma The mean of Olig2 LI of gliomas with 1p/19q loss ± IDH1/2 mutation, the majority... BeFree 25085214 Detail
<0.001 Hyperplastic Polyp NA BeFree Detail
<0.001 anaplastic astrocytoma NA BeFree Detail
<0.001 pilocytic astrocytoma NA BeFree Detail
0.001 anaplastic oligodendroglioma The means of Olig2 LI in glioma cells were 43.7 % in diffuse astrocytomas, 59.3 ... BeFree 25085214 Detail
<0.001 clear cell meningioma NA BeFree Detail
<0.001 Malignant glioma NA BeFree Detail
<0.001 Carcinogenesis NA BeFree Detail
<0.001 Leukemogenesis NA BeFree Detail
<0.001 breast carcinoma NA BeFree Detail
<0.001 Ewings sarcoma-primitive neuroectodermal tumor (PNET) NA BeFree Detail
<0.001 Substance abuse problem NA BeFree Detail
0.003 Well Differentiated Oligodendroglioma The means of Olig2 LI in glioma cells were 43.7 % in diffuse astrocytomas, 59.3 ... BeFree 25085214 Detail
<0.001 Precursor T-cell lymphoblastic lymphoma NA BeFree Detail
<0.001 tanycytic ependymoma Immunohistochemical and ultrastructural observations revealed that all the tumor... BeFree 24612193 Detail
0.003 Mammary Neoplasms NA LHGDN Detail
<0.001 Glioblastoma multiforme NA BeFree Detail
<0.001 Neurocytoma NA BeFree Detail
<0.001 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma NA BeFree Detail
<0.001 pituicytoma NA BeFree Detail
<0.001 Thymus Neoplasms NA BeFree Detail
0.002 Alzheimer's disease NA GAD Detail
<0.001 amyotrophic lateral sclerosis NA BeFree Detail
<0.001 anorexia nervosa NA BeFree Detail
0.007 Astrocytoma NA BeFree,LHGDN Detail
<0.001 Mental disorders NA BeFree Detail
0.001 Brain Neoplasms NA BeFree Detail
<0.001 Malignant neoplasm of breast NA BeFree Detail
Annotation

Annotations

DescrptionSourceLinks
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
Identification of OLIG2 as the most specific glioblastoma stem cell marker starting from comparative... DisGeNET Detail
OSM enhanced transcript and protein level of fibronectin and YKL-40 and reduced the expression of Ol... DisGeNET Detail
Induction of the miR-302/367 cluster in extensively mutated U87MG glioblastoma cells drastically sup... DisGeNET Detail
Olig2 labeling index is correlated with histological and molecular classifications in low-grade diff... DisGeNET Detail
OLIG2, a proliferation regulator and glioma progenitor cell marker upregulated in IGCs was found to ... DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
Re-expression of MAL and OLIG2 to physiological levels dramatically reduced the growth of lung tumor... DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
The means of Olig2 LI in glioma cells were 43.7 % in diffuse astrocytomas, 59.3 % in oligoastrocytom... DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
Immunohistochemical and ultrastructural observations revealed that all the tumors were ependymal in ... DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
Five SNPs achieved 0.004 (the nominal p-value expected by chance), 3 with empirical significant p-va... DisGeNET Detail
Five SNPs achieved 0.004 (the nominal p-value expected by chance), 3 with empirical significant p-va... DisGeNET Detail
Five SNPs achieved 0.004 (the nominal p-value expected by chance), 3 with empirical significant p-va... DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
The mean of Olig2 LI of gliomas with 1p/19q loss ± IDH1/2 mutation, the majority of them being oligo... DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
The means of Olig2 LI in glioma cells were 43.7 % in diffuse astrocytomas, 59.3 % in oligoastrocytom... DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
The means of Olig2 LI in glioma cells were 43.7 % in diffuse astrocytomas, 59.3 % in oligoastrocytom... DisGeNET Detail
NA DisGeNET Detail
Immunohistochemical and ultrastructural observations revealed that all the tumors were ependymal in ... DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail

Overlapped Transcript Coordinates

Gene Transcript ID Exon Number Chromosome Start Stop Type Amino Mutation Transcript Position Links

Overlapped Transcript

Gene Transcript ID Chromosome Start Stop Links
Gene
-
dbSNP
rs1074815 dbSNP
Genome
hg38
Position
chr21:33,025,935-33,029,196
Variant Type
snv
Genome browser